Cite
MLA Citation
Dennis D. H. Kim et al.. “Optimal duration of imatinib treatment/deep molecular response for treatment‐free remission after imatinib discontinuation from a Canadian tyrosine kinase inhibitor discontinuation trial.” British journal of haematology, vol. 193, 2021, pp. 779–791. http://access.bl.uk/ark:/81055/vdc_100130249894.0x000062